Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Polycythemia Vera × Melphalan × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic Syndromes 5 Multiple Myeloma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Hematologic Neoplasms 3 Neuroblastoma 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Hematologic Diseases 2 Venentoclax 1 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rasmussen subacute encephalitis 1 Primary Myelofibrosis 1 Preleukemia 1 Precancerous Conditions 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Osteosarcoma 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasms by Histologic Type 1 Neoplasms 1

Interventions

ruxolitinib 2 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Panobinostat 1 Injections 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡